Symbol="ALT"
AssetType="Common Stock"
Name="Altimmune Inc"
Description="Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland."
CIK="1326190"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="127912000"
EBITDA="-87612664"
PERatio="None"
PEGRatio="0"
BookValue="3.185"
DividendPerShare="0"
DividendYield="0"
EPS="-1.68"
RevenuePerShareTTM="-0.002"
ProfitMargin="0"
OperatingMarginTTM="1081.63"
ReturnOnAssetsTTM="-0.279"
ReturnOnEquityTTM="-0.449"
RevenueTTM="-81000"
GrossProfitTTM="-70520000"
DilutedEPSTTM="-1.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.25"
AnalystTargetPrice="19.38"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="162.98"
PriceToBookRatio="2.585"
EVToRevenue="99.22"
EVToEBITDA="-3.792"
Beta="-0.0973"
num_52WeekHigh="23.49"
num_52WeekLow="2.34"
num_50DayMovingAverage="3.155"
num_200DayMovingAverage="7.66"
SharesOutstanding="52686000"
DividendDate="2018-09-14"
ExDividendDate="2017-01-20"
symbol="ALT"
open="2.48"
high="2.50"
low="2.38"
price="2.50"
volume="654203.00"
latest_trading_day="2023-08-30"
previous_close="2.47"
change="0.03"
change_percent="1.2146%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="95"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="5"
Volume_recent_avg="1664408"
Change_recent_avg="-0.03"
Delta_recent_avg="0.23"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-1.0"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="5"
Aroon_momentum_negative="95"
image_negative_thumbnail_id_1="1137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="564"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="660"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_positive_thumbnail_id_2="1006"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
